Emerging pneumonia-like illness "legionellosis" in Argentina in the COVID-19 era: Cause to panic?

Front Pharmacol. 2022 Nov 8:13:1063237. doi: 10.3389/fphar.2022.1063237. eCollection 2022.

Ranjan K Mohapatra¹, Ahmed Mahal^{2

3

4}, Venkataramana Kandi⁵, L V Simhachalam Kutikuppala⁶, Ashish K Sarangi⁷, Snehasish Mishra⁸

¹ Department of Chemistry, Government College of Engineering, Keonjhar, Odisha, India.
² Department of Medical Biochemical Analysis, College of Health Technology, Cihan University-Erbil, Erbil, Kurdistan Region, Iraq.
³ Key Laboratory of Plant Resources Conservation and Sustainable Utilization, Guangdong Provincial Key Laboratory of Applied Botany, South China Botanical Garden, Chinese Academy of Sciences, Guangzhou, China.
⁴ Guangzhou HC Pharmaceutical Co., Ltd., Guangzhou, China.
⁵ Department of Microbiology, Prathima Institute of Medical Sciences, Karimnagar, Telangana, India.
⁶ Department of General Surgery, Dr. NTR University of Health Sciences, Vijayawada, Andhra Pradesh, India.
⁷ Department of Chemistry, School of Applied Sciences, Centurion University of Technology and Management, Odisha, India.
⁸ School of Biotechnology, Campus-11, KIIT Deemed-to-be-University, Bhubaneswar, Odisha, India.

No abstract available

Keywords: complications; epidemiology; legionellosis; prevention and control measures; transmission route.